# China NMPA Drug Inspection - Huizhou Daya Pharmaceutical Co., Ltd. - Ibuprofen extended-release tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/huizhou-daya-pharmaceutical-co-ltd/da36e902-3ebb-44e9-ab24-4ead7e9915cc/
Source feed: China

> China NMPA drug inspection for Huizhou Daya Pharmaceutical Co., Ltd. published June 17, 2021. Drug: Ibuprofen extended-release tablets. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 4, 2021)
- Company Name: Huizhou Daya Pharmaceutical Co., Ltd.
- Publication Date: 2021-06-17
- Drug Name: Ibuprofen extended-release tablets
- Inspection Finding: Meets the requirements of drug standards (qualified)
- Action Taken: It does not involve the investigation and handling of substandard drugs.

Company: https://www.globalkeysolutions.net/companies/huizhou-daya-pharmaceutical-co-ltd/f78e402f-1041-4701-8372-bf90e6fad619/